NEW YORK – What were the articles that gained the most interest from GenomeWeb readers last week? Here are the top five:
- FDA Letter Warns About False-Positive Results From Becton Dickinson SARS-CoV-2 Test
- FDA Issues New Guidance for SARS-CoV-2 Pooled Sample Testing
- Thermo Fisher Scientific, Chugai Pharmaceutical Sign Companion Diagnostic Agreement for NSCLC
- Qiagen Reports Preliminary Q2 Revenue Growth of 18 to 19 Percent
- Progenity Asks Court to Declare Non-Infringement of Natera Patents